Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic (IVD) Trends and Market Update: March 2024" report has been added to ResearchAndMarkets.com's offering.
This report provides the most current insights into these trends and others shaping the market.
Diagnostic testing has become a fundamental aspect of healthcare, aiding physicians in diagnosing conditions and determining treatments. Despite a decline in COVID-19 testing affecting total revenues, core diagnostic segments have generally experienced growth. Factors such as new products, changes in global health spending, regulatory shifts, and disease trends contribute to a constantly changing market, yet one that remains resilient.
Key growing segments attracting industry attention include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also of significant interest, and expected to play a crucial role in the future of IVD. The IVD market remains dynamic, characterized by constant innovations.
In In Vitro Diagnostic (IVD) Trends and Market Update: March 2024, you'll discover:
- What's Driving Growth in the IVD Market in 2024
- What Major Trends are Affecting the Market in 2024
- What Product Trends and New Developments Will Shape the IVD Market in 2024
Trends highlighted throughout 2023 and into 2024 include:
- Growing interest in multiplex disease testing
- Increasing interest in digital diagnostics, combining data and analytics with traditional IVD
- Continued advancement of AI technologies
- Growth in rapid and POC testing
- And much more
Key Topics Covered:
Chapter 1: Worldwide Ivd Market - March 2024 Update
- Ivd Market Demand and Growth
- COVID-19 Diagnostic Markets
- Effect of COVID-19 on Market Segments
Chapter 2: Product Trends and New Developments
- Selected New - Q4 2023 and Q1 2024 - Core Ivd Product Launches, Developments and Trends
- Immunoassay
- Molecular
- Personalized Medicine and Genetic Testing
- Poc
- Sequencing
- Microbiology
- Selected COVID-19 Developments - Q4 2023 - Q1 2024
Chapter 3: Top Ivd Market Participant Results
- Selected Competitive Leader Updates
- Q4 2023, Q1 2024 M&A Activity
- Abbott Laboratories
- Becton Dickinson and Co
- Biomerieux SA
- Danaher Corporation
- Exact Sciences, Inc.
- Hologic, Inc.
- Quidelortho Corporation
- Roche Diagnostic
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
Chapter 4: New Opportunities
- Artificial Intelligence Future Trends
- At-Home Testing
- Multiplex Testing
- Telehealth
For more information about this report visit https://www.researchandmarkets.com/r/7x4bfl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
